chr1-119140608-A-C

Variant summary

Our verdict is Likely pathogenic. The variant received 6 ACMG points: 7P and 1B. PS3PM5PP5BP4

The NM_015836.4(WARS2):​c.37T>G​(p.Trp13Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00359 in 1,613,944 control chromosomes in the GnomAD database, including 22 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). ClinVar reports functional evidence for this variant: "SCV001142303: Functional studies demonstrate that c.37T>G has affected a mitochondrial signal peptide (SP) leading to mislocalization of the mutant protein in the cells. PMID:28236339" and additional evidence is available in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. W13R) has been classified as Likely pathogenic.

Frequency

Genomes: š‘“ 0.0031 ( 0 hom., cov: 33)
Exomes š‘“: 0.0036 ( 22 hom. )

Consequence

WARS2
NM_015836.4 missense

Scores

2
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:16U:4B:2

Conservation

PhyloP100: -0.145

Publications

25 publications found
Variant links:
Genes affected
WARS2 (HGNC:12730): (tryptophanyl tRNA synthetase 2, mitochondrial) Aminoacyl-tRNA synthetases catalyze the aminoacylation of tRNA by their cognate amino acid. Because of their central role in linking amino acids with nucleotide triplets contained in tRNAs, aminoacyl-tRNA synthetases are thought to be among the first proteins that appeared in evolution. Two forms of tryptophanyl-tRNA synthetase exist, a cytoplasmic form, named WARS, and a mitochondrial form, named WARS2. This gene encodes the mitochondrial tryptophanyl-tRNA synthetase. Two alternative transcripts encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
WARS2-AS1 (HGNC:40612): (WARS2 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_pathogenic. The variant received 6 ACMG points.

PS3
PS3 evidence extracted from ClinVar submissions: SCV001142303: Functional studies demonstrate that c.37T>G has affected a mitochondrial signal peptide (SP) leading to mislocalization of the mutant protein in the cells. PMID: 28236339; SCV001445976: "In vitro functional studies provide some evidence that the variant may impact protein function." PMID:29120065, 28236339; SCV006583096: "Functional studies provide moderate evidence of the variant having a damaging effect on the gene or gene product." PMID: 28236339, 29120065; SCV003933944: Several publications report experimental evidence evaluating an impact on protein function and these studies showed that the variant results in decreased (but not absent) mitochondrial localization in vitro (Musante_2017), and reduced WARS2 protein levels, with impaired mitochondrial respiratory chain activity in fibroblasts derived from compound heterozygous patients (e.g. Burke_2018, Martinelli_2020, Skorvanek_2022). PMID:33619735, 29120065, 31970218, 35074316, 32120303, 28236339, 30831263, 39073549, 34890876; SCV004109532: "In vitro study showed this variant may affect the mitochondrial localization signal (Musante et al. 2017. PubMed ID: 28236339)."; SCV004847426: "In vitro studies provide some evidence that this variant impacts protein function by impairing mitochondrial localization and a reduction of protein level and consequently affecting mitochondrial respiratory chain activity (Musante 2017 PMID: 28236339, Burke 2018 PMID: 29120065)"
PM5
Other missense variant is known to change same aminoacid residue: Variant chr1-119140608-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 1947813.
PP5
Variant 1-119140608-A-C is Pathogenic according to our data. Variant chr1-119140608-A-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 440915.
BP4
Computational evidence support a benign effect (MetaRNN=0.0043417513). . Strength limited to SUPPORTING due to the PP5.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_015836.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
WARS2
NM_015836.4
MANE Select
c.37T>Gp.Trp13Gly
missense
Exon 1 of 6NP_056651.1Q9UGM6-1
WARS2
NM_001378228.1
c.37T>Gp.Trp13Gly
missense
Exon 1 of 6NP_001365157.1B7Z6G7
WARS2
NM_001378229.1
c.37T>Gp.Trp13Gly
missense
Exon 1 of 5NP_001365158.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
WARS2
ENST00000235521.5
TSL:1 MANE Select
c.37T>Gp.Trp13Gly
missense
Exon 1 of 6ENSP00000235521.4Q9UGM6-1
WARS2
ENST00000369426.9
TSL:1
c.37T>Gp.Trp13Gly
missense
Exon 1 of 6ENSP00000358434.5Q9UGM6-2
WARS2-AS1
ENST00000425884.7
TSL:1
n.213A>C
non_coding_transcript_exon
Exon 1 of 4

Frequencies

GnomAD3 genomes
AF:
0.00315
AC:
480
AN:
152276
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000844
Gnomad AMI
AF:
0.00439
Gnomad AMR
AF:
0.00419
Gnomad ASJ
AF:
0.00230
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00393
Gnomad FIN
AF:
0.000470
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00489
Gnomad OTH
AF:
0.00478
GnomAD2 exomes
AF:
0.00322
AC:
809
AN:
250992
AF XY:
0.00352
show subpopulations
Gnomad AFR exome
AF:
0.000555
Gnomad AMR exome
AF:
0.00357
Gnomad ASJ exome
AF:
0.00119
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000695
Gnomad NFE exome
AF:
0.00436
Gnomad OTH exome
AF:
0.00636
GnomAD4 exome
AF:
0.00363
AC:
5311
AN:
1461550
Hom.:
22
Cov.:
30
AF XY:
0.00372
AC XY:
2703
AN XY:
727072
show subpopulations
African (AFR)
AF:
0.000478
AC:
16
AN:
33468
American (AMR)
AF:
0.00418
AC:
187
AN:
44694
Ashkenazi Jewish (ASJ)
AF:
0.00119
AC:
31
AN:
26122
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39694
South Asian (SAS)
AF:
0.00369
AC:
318
AN:
86218
European-Finnish (FIN)
AF:
0.000880
AC:
47
AN:
53380
Middle Eastern (MID)
AF:
0.00780
AC:
45
AN:
5766
European-Non Finnish (NFE)
AF:
0.00398
AC:
4423
AN:
1111822
Other (OTH)
AF:
0.00404
AC:
244
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
273
547
820
1094
1367
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
152
304
456
608
760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00315
AC:
480
AN:
152394
Hom.:
0
Cov.:
33
AF XY:
0.00305
AC XY:
227
AN XY:
74520
show subpopulations
African (AFR)
AF:
0.000841
AC:
35
AN:
41604
American (AMR)
AF:
0.00418
AC:
64
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.00230
AC:
8
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00393
AC:
19
AN:
4832
European-Finnish (FIN)
AF:
0.000470
AC:
5
AN:
10632
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.00489
AC:
333
AN:
68040
Other (OTH)
AF:
0.00473
AC:
10
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
24
49
73
98
122
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00399
Hom.:
4
Bravo
AF:
0.00300
TwinsUK
AF:
0.00351
AC:
13
ALSPAC
AF:
0.00285
AC:
11
ESP6500AA
AF:
0.000681
AC:
3
ESP6500EA
AF:
0.00372
AC:
32
ExAC
AF:
0.00331
AC:
402
EpiCase
AF:
0.00616
EpiControl
AF:
0.00510

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
6
1
-
Neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures (7)
3
2
-
Parkinsonism-dystonia 3, childhood-onset (5)
2
-
2
not provided (4)
3
-
-
WARS2-related disorder (3)
-
1
-
Inborn genetic diseases (1)
1
-
-
Neurodevelopmental disorder (1)
1
-
-
Neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures;C5676913:Parkinsonism-dystonia 3, childhood-onset (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.45
T
BayesDel_noAF
Benign
-0.42
CADD
Benign
16
DANN
Benign
0.89
DEOGEN2
Benign
0.11
T
Eigen
Benign
-0.55
Eigen_PC
Benign
-0.46
FATHMM_MKL
Benign
0.12
N
LIST_S2
Benign
0.63
T
M_CAP
Benign
0.0056
T
MetaRNN
Benign
0.0043
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Uncertain
2.1
M
PhyloP100
-0.14
PrimateAI
Benign
0.34
T
PROVEAN
Benign
-0.74
N
REVEL
Benign
0.12
Sift
Benign
0.081
T
Sift4G
Uncertain
0.016
D
Polyphen
0.0010
B
Vest4
0.43
MVP
0.25
MPC
0.74
ClinPred
0.037
T
GERP RS
0.72
PromoterAI
-0.19
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.17
gMVP
0.62
Mutation Taster
=87/13
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs139548132; hg19: chr1-119683231; COSMIC: COSV99346234; COSMIC: COSV99346234; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.